Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This month entities : Gilead sciences, inc. save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -100.0%
H: NaN%
C: Infinity%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
CTXR | $0.7199 -6.18% -6.58% 880K
|
Health Technology
|
| O: 2.33%
H: 2.28%
C: -4.23%
hope treatment pharmaceuticals city for car-t trial
Leap Therapeutics Announces $40 Million Private Placement
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
LPTX | $3.285 2.66% 2.59% 190K
|
Health Technology
|
| O: 15.13%
H: 25.43%
C: -11.0%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: 0.5%
H: 0.83%
C: 0.28%
million leap therapeutics
Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024
Published: 2024-04-08 (Crawled : 23:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
gilead first sciences financial results
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
Published: 2024-04-08 (Crawled : 13:30) - prnewswire.com
RDHL | $0.415 -2.99% -3.08% 190K
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: -1.5%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.76%
H: 0.72%
C: 0.54%
biopharma results
Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer
Published: 2024-04-02 (Crawled : 20:00) - globenewswire.com
RMD | $183.78 -0.24% 0.0% 970K
|
Health Technology
|
| O: 0.88%
H: 1.64%
C: 0.03%
LUNG | $7.525 0.33% 0.33% 200K
|
Health Technology
|
| O: 0.59%
H: 1.64%
C: -7.13%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.12%
H: 0.24%
C: -1.54%
financial
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 20:00) - globenewswire.com
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.08%
H: 0.04%
C: -1.0%
business year pipeline therapeutics financial results
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.